Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients with advanced or metastatic solid tumors, ...

Lument Finance Trust ( ($LFT) ) has shared an announcement. On November 24, 2025, Lument Commercial Mortgage Trust, a subsidiary of Lument Finance ...

Lument Finance Trust, Inc.  ("we,"; "LFT" or the "Company") today announced that it closed LMNT 2025-FL3, a $663.8 million ...

Clinicians Laura Huppert, Kelsey Natsuhara, and Magdelena Ford discuss the evidence, challenges, and real-world ...

Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared ...

The 2025 AAO‐HNSF adult sinusitis guideline, an update of the 2015 guideline, offers evidence-based recommendations on rhinosinusitis management.

Hello, and welcome to Wave Life Sciences Positive Interim Clinical Data from INLIGHT Trial of WVE-007 and Obesity call. [Operator Instructions]. Also, as a reminder, this conference is being recorded ...

The clinical-stage biotechnology company announced that a single 240 mg dose of WVE-007 demonstrated improved body composition after three months, including a 9.4% reduction in visceral fat, a 4.5% ...

SIR Royalty Income Fund ("the Fund") today declared a cash distribution of $0.10 per unit for the period November 1, 2025 to November 30, 2025 (the "December Distribution"). The Fund also declared a ...

This article was reviewed by Felix Gussone, MD. Why Is Blood Work Important for Men’s Health? Key Takeaways Blood work gives you a snapshot of your ...

Citi Annual Global Healthcare Conference 2025 December 3, 2025 9:00 AM ESTCompany ParticipantsDavid Hung - Founder, President, ...